The hypoxic microenvironment of GBM further promotes tumor progression through hypoxia-inducible factor 1-alpha (HIF-1α) activation and vascular endothelial growth factor (VEGF)-driven angiogenesis, enhancing invasion and limiting therapeutic efficacy [26]. This evidence concerns the gene HIF1A and glioblastoma.